# US 2012/0253464 A1 · Scaffold for connective tissue repair

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253464 A1
- Document ID: US20120253464A1
- Status: Published application
- Kind: A1
- Application number: 13/491,985
- Filed: 2012-06-08
- Published: 2012-10-04
- Earliest claimed: 2003-06-30
- Assignees: DePuy Mitek, LLC
- Inventors: Julia Hwang; Joseph Hammer; Herb Schwartz; Prasanna Malaviya
- Web page: https://patentgrep.com/patent/US20120253464A1

## CPC

- A61L 27/3604: {characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel}
- A61F 2/08: Muscles; Tendons; Ligaments
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/3641: {characterised by the site of application in the body (materials for artificial blood vessels A61L27/507; materials for use in artificial skin A61L27/60)}
- A61L 27/3645: {Connective tissue}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61F 2002/0852: {Fixation of a loop or U-turn, e.g. eyelets, anchor having multiple holes}
- A61F 2210/0004: bioabsorbable
- A61F 2250/0015: differing in density or specific weight
- A61F 2250/0028: differing in fibre orientations
- A61L 27/3662: {Ligaments, tendons}
- A61L 27/3691: {characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation}
- A61L 27/58: Materials at least partially resorbable by the body
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A connective tissue scaffold including opposed first and second anchoring segments formed from a plurality of bioresorbable polymeric fibers oriented in a direction substantially parallel to a longitudinal axis of the scaffold and a plurality of bioresorbable polymeric fibers oriented in a direction substantially transverse to a longitudinal axis of the scaffold. A central segment joins the first and second anchoring segments and includes a plurality of bioresorbable polymeric fibers oriented in a direction substantially parallel to the longitudinal axis of the scaffold. The scaffold can also a tissue particle and/or biological component.

## Claims

### Claim 1

A connective tissue scaffold, comprising:
opposed first and second anchoring eyelets formed of a plurality of bioresorbable polymeric fibers and defining an open area;
first and second binding regions adjacent the opposed first and second eyelets, the first and second binding regions being formed of a plurality of bioresorbable polymeric fibers oriented in a direction substantially parallel to a longitudinal axis of the scaffold and in a direction that is not substantially parallel to the longitudinal axis; and
a central segment, adjoining the first and second binding regions, formed of a plurality of bioresorbable polymeric fibers oriented in a direction substantially parallel to the longitudinal axis of the scaffold.

### Claim 2 (depends on 1)

The scaffold of claim 1, wherein the fibers of the first and second binding regions are joined in a weave pattern.

### Claim 3 (depends on 1)

The scaffold of claim 1, wherein the scaffold further includes a biocompatible, bioresorbable material covering at least a portion of the first and second binding regions and the central segment.

### Claim 4 (depends on 3)

The scaffold of claim 3, wherein the bioresorbable material is a biological material.

### Claim 5 (depends on 4)

The scaffold of claim 4, wherein the bioresorbable material is small intestine submucosa.

### Claim 6 (depends on 3)

The scaffold of claim 3, wherein the bioresorbable material is formed over the first and second anchoring eyelets, the first and second binding regions, and the central segment as a wrap, sleeve, or sheath.

### Claim 7 (depends on 1)

The scaffold of claim 1, further comprising at least one minced tissue particle that is associated with at least a portion of the scaffold, wherein the at least one minced tissue particle includes an effective amount of viable cells that can migrate out of the at least one minced tissue particle and populate the scaffold.

### Claim 8 (depends on 7)

The scaffold of claim 7, where in the at least one minced tissue particle comprises a bone-free tissue type selected from the group consisting of tendon, ligament, patellar tendon, anterior cruciate ligament, posterior cruciate ligament, medial collateral ligament, lateral collateral ligament, periosteum, perichondrium, iliotibial band or fascia lata, gracilis tendon, semitendinosis tendon, synovium, skin and combinations thereof.

### Claim 9 (depends on 7)

The scaffold of claim 7, wherein the at least one minced tissue particle comprises a bone tissue type that is placed in the first and second anchoring segments of the scaffold.

### Claim 10 (depends on 7)

The scaffold of claim 7, wherein the scaffold further comprises an adhesion agent.

### Claim 11 (depends on 10)

The scaffold of claim 10, wherein the adhesion agent comprises an anchoring agent selected from the group consisting of hyaluronic acid, fibrin glue, fibrin clot, collagen gel, gelatin-resorcin-formalin adhesive, mussel-based adhesive, dihydroxyphenylalanine (DOPA) based adhesive, chitosan, transglutaminase, poly(amino acid)-based adhesive, cellulose-based adhesive, synthetic acrylate-based adhesives, platelet rich plasma (PRP), Matrigel, Monostearoyl Glycerol co-Succinate (MGSA), Monostearoyl Glycerol co-Succinate/polyethylene glycol (MGSA/PEG) copolymers, laminin, elastin, proteoglycans, and combinations thereof.

### Claim 12 (depends on 10)

The scaffold of claim 10, wherein the adhesion agent comprises a cross-linking agent selected from the group consisting of divinyl sulfone (DVS), polyethylene glycol divinyl sulfone (VS-PEG-VS), hydroxyethyl methacrylate divinyl sulfone (HEMA-DIS-HEMA), formaldehyde, glutaraldehyde, aldehydes, isocyanates, alkyl and aryl halides, imidoesters, N-substituted maleimides, acylating compounds, carbodiimide, hydroxychloride, N-hydroxysuccinimide, light, pH, temperature, and combinations thereof.

### Claim 13 (depends on 1)

The scaffold of claim 1, wherein the bioresorbable polymeric fibers of the scaffold are made from polymers or copolymers formed from monomers selected from the group consisting of lactide, glycolide, dioxanone, and caprolactone.

### Claim 14 (depends on 13)

The scaffold of claim 13, wherein the bioresorbable polymeric fibers of the scaffold are made from a copolymer having a ratio of monomers of about 95:5 lactide and glycolide.

### Claim 15 (depends on 1)

The scaffold of claim 1, wherein the scaffold comprises a ligament graft.

### Claim 16 (depends on 15)

The scaffold of claim 15, wherein the scaffold comprises a cruciate ligament graft.

### Claim 17 (depends on 7)

The scaffold of claim 7, wherein the scaffold further comprises at least one additional biological component applied thereto.

### Claim 18 (depends on 17)

The scaffold of claim 17, wherein the at least one additional biological component comprises heterologous or autologous growth factors, proteins, matrix proteins, peptides, antibodies, antibiotics, anti-inflammatories, chemotactic agents, cell attachment mediators, biologically active ligands, integrin binding sequence, enzymes, cytokines, glycosaminoglycans, viruses, virus particles, nucleic acids, analgesics, cells, platelets, and combinations thereof.
